A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia

Wang Yin1, Weiwei Jiang2, Qi He2, Cheng Wang3, Baoju Wang4, Pan Zhou5, Nianguo Dong1, Qiaoxia Tong4
1Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 43000, China
2Department of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 43000, China
3Department of Rheumatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 43000, China
4Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 43000, China
5Department of Hand Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 43000, China

Tóm tắt

Từ khóa


Tài liệu tham khảo

Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727–733 (2020).

Xu, Z. et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 8, 420–422 (2020).

Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506 (2020).

Wu, C. et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern. Med. e200994 (2020). [published online ahead of print, 2020 Mar 13]. https://doi.org/10.1001/jamainternmed.2020.0994.

Zhou, W. et al. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia. Signal Transduct. Target Ther. 5, 18 (2020).